We have identified four particular areas of expertise, shown in the diagram below. As at 31 July 2014, the value of the top 20 investments in our portfolio stood at £234.7 million.
A clinical-stage specialty biopharmaceutical company developing a range of novel immunotherapies
Complete replacement for knee meniscus
Internet of Things solutions provider specialising in fully integrated business solutions around connected product intelligence.